Johnson & Johnson
Johnson & Johnson (JNJ) Wheel Strategy
JNJ wheel strategy scan found 261 cash-secured put setups on the previous trading day. Probability of expiring worthless is above 50%. Annualized returns reach up to 65.1%.
Read more
Running a JNJ wheel strategy lets you generate consistent premium income on Johnson & Johnson while setting your own entry and exit prices on the underlying. Johnson & Johnson's wheel combines cash-secured puts and covered calls into a repeatable cycle: sell puts at strikes where you'd be happy to own JNJ, and if assigned, sell calls at strikes where you'd be happy to sell. Use our scanner to find the best JNJ wheel strategy setups in real time.
The wheel works best on liquid, high-quality names with stable fundamentals and active options markets — exactly the profile many large-cap leaders fit. The mechanics are simple: sell a cash-secured put on JNJ, collect premium, and either keep the premium if it expires worthless or take assignment at a discount to current price. Once assigned, sell covered calls against the shares to keep collecting premium until they're called away. Choosing the right strikes, expirations, and IV environment is what separates a profitable JNJ wheel from a losing one.
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand.
Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
The difference between a wheel that compounds and one that bleeds comes down to strike selection, IV timing, and discipline on assignment. Our scanner handles the heavy lifting: it ranks every leg of the JNJ wheel strategy by delta, premium yield, IV rank, and days to expiration, so you can deploy capital where the math works. Build your JNJ wheel strategy on data, not gut feel — and let the options wheel do what it does best: pay you to wait.
| Oct 2, 2026 | 270.00 | $1.57 | $1.93 | -0.38 | 4 | 87% | 60.5% | 65.1% | 662 |
| Oct 16, 2026 | 270.00 | $5.40 | $5.60 | -0.43 | 18 | 87% | 54.9% | 42.1% | 887 |
| Oct 9, 2026 | 270.00 | $3.15 | $3.30 | -0.41 | 11 | 87% | 56.3% | 40.6% | 86 |
| Oct 2, 2026 | 267.50 | $1.00 | $1.19 | -0.26 | 4 | 87% | 72.8% | 40.4% | 60 |
| Oct 16, 2026 | 267.50 | $3.90 | $4.48 | -0.37 | 18 | 87% | 61.0% | 33.9% | 16 |
| Oct 23, 2026 | 270.00 | $5.60 | $6.15 | -0.43 | 25 | 87% | 54.2% | 33.3% | 37 |
| Oct 30, 2026 | 270.00 | $6.75 | $7.13 | -0.43 | 32 | 87% | 53.8% | 30.1% | 46 |
| Oct 9, 2026 | 267.50 | $2.21 | $2.41 | -0.32 | 11 | 87% | 64.0% | 29.8% | 39 |
| Oct 16, 2026 | 265.00 | $3.40 | $3.78 | -0.32 | 18 | 87% | 66.9% | 28.9% | 17 |
| Nov 6, 2026 | 270.00 | $6.90 | $7.75 | -0.43 | 39 | 87% | 53.4% | 26.9% | 1 |
As of September 28, 2026
Run the Wheel on JNJ With Confidence
Find the best JNJ wheel strategy setups across strikes and expirations, plan ahead with at-strike values, and keep your covered calls and puts on track.
Start your 14-day free trial→